A Meta-Analysis of Apolipoprotein E Gene ε2/ε3/ε4 Polymorphism for Gallbladder Stone Disease

PLoS ONE

Volumn 7, Issue 9, 2012, Pages

  Xue, Pei ^a   Niu, Wen Quan ^c   Jiang, Zhao Yan ^a,b   Zheng, Min Hua ^a   Fei, Jian ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b Shanghai Institute of Digestive Surgery   (China)

^c Shanghai Institute of Hypertension   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; APOLIPOPROTEIN E EPSILON 2 GENE; APOLIPOPROTEIN E EPSILON 3 GENE; APOLIPOPROTEIN E EPSILON 4 GENE; ARTICLE; CHOLELITHIASIS; CLINICAL EVALUATION; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE; GENE FREQUENCY; GENE FUNCTION; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENETIC MODEL; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MOLECULAR PATHOLOGY; RISK ASSESSMENT; RISK REDUCTION;

ADULT; ALLELES; APOLIPOPROTEIN E2; APOLIPOPROTEIN E3; APOLIPOPROTEIN E4; ASIAN CONTINENTAL ANCESTRY GROUP; FEMALE; GALLSTONES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; MODELS, GENETIC; ODDS RATIO; PHENOTYPE; POLYMORPHISM, GENETIC; PROTEIN ISOFORMS; RISK FACTORS;

EID: 84866715762     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0045849     Document Type: Article

References (28)

1. Everhart JE, (2001) Gallstones and ethnicity in the Americas. J Assoc Acad Minor Phys 12: 137-143.
2. Mella JG, Schirin-Sokhan R, Rigotti A, Pimentel F, Villarroel L, et al. (2007) Genetic evidence that apolipoprotein E4 is not a relevant susceptibility factor for cholelithiasis in two high-risk populations. The Journal of Lipid Research 48: 1378-1385.
3. Kesaniemi YA, Ehnholm C, Miettinen TA, (1987) Intestinal cholesterol absorption efficiency in man is related to apoprotein E phenotype. J Clin Invest 80: 578-581.
4. Weintraub MS, Eisenberg S, Breslow JL, (1987) Dietary fat clearance in normal subjects is regulated by genetic variation in apolipoprotein E. J Clin Invest. 80: 1571-1577.
5. Cohn LD, Becker BJ, (2003) How meta-analysis increases statistical power. Psychol Methods 8: 243-253.
6. Higgins JP, Thompson SG, Deeks JJ, Altman DG, (2003) Measuring inconsistency in meta-analyses. BMJ 327: 557-560.
7. Niu W, Qi Y, Qian Y, Gao P, Zhu D, (2009) The relationship between apolipoprotein E epsilon2/epsilon3/epsilon4 polymorphisms and hypertension: a meta-analysis of six studies comprising 1812 cases and 1762 controls. Hypertens Res 32: 1060-1066.
8. Niu W, Qi Y, (2011) An updated meta-analysis of endothelial nitric oxide synthase gene: three well-characterized polymorphisms with hypertension. PLoS One 6: e24266.
9. Niu W, Qi Y, (2011) Association of alpha-adducin and G-protein beta3 genetic polymorphisms with hypertension: a meta-analysis of Chinese populations. PLoS One 6: e17052.
10. Niemi M, Kervinen K, Rantala A, Kauma H, Paivansalo M, et al. (1999) The role of apolipoprotein E and glucose intolerance in gallstone disease in middle aged subjects. Gut 44: 557-562.
11. Jaime S-C, (2010) ApoB-100, ApoE and CYP7A1 gene polymorphisms in Mexican patients with cholesterol gallstone disease. World Journal of Gastroenterology 16: 4685.
12. Jiang ZY, Han TQ, Suo GJ, Feng DX, Chen S, et al. (2004) Polymorphisms at cholesterol 7alpha-hydroxylase, apolipoproteins B and E and low density lipoprotein receptor genes in patients with gallbladder stone disease. World J Gastroenterol 10: 1508-1512.
13. Vanerpecum K, Portincasa P, Dohlu M, Vanbergehenegouwen G, Jungst D, (2003) Biliary pronucleating proteins and apolipoprotein E in cholesterol and pigment stone patients. Journal of Hepatology 39: 7-11.
14. Dixit M, Choudhuri G, Mittal B, (2006) Association of APOE-C1 gene cluster polymorphisms with gallstone disease. Dig Liver Dis 38: 397-403.
15. Bertomeu A, Ros E, Zambon D, Vela M, Perez-Ayuso RM, et al. (1996) Apolipoprotein E polymorphism and gallstones. Gastroenterology 111: 1603-1610.
16. Abu Abeid S, Szold A, Gavert N, Goldiner I, Grynberg E, et al. (2002) Apolipoprotein-E genotype and the risk of developing cholelithiasis following bariatric surgery: a clue to prevention of routine prophylactic cholecystectomy. Obes Surg 12: 354-357.
17. Ko CW, Beresford SA, Alderman B, Jarvik GP, Schulte SJ, et al. (2000) Apolipoprotein E genotype and the risk of gallbladder disease in pregnancy. Hepatology 31: 18-23.
18. Hasegawa K, (2003) Effect of apolipoprotein E polymorphism on bile lipid composition and the formation of cholesterol gallstone. The American Journal of Gastroenterology 98: 1605-1609.
19. Davignon J, Gregg RE, Sing CF, (1988) Apolipoprotein E polymorphism and atherosclerosis. Arteriosclerosis 8: 1-21.
20. Poirier J, Davignon J, Bouthillier D, Kogan S, Bertrand P, et al. (1993) Apolipoprotein E polymorphism and Alzheimer's disease. Lancet 342: 697-699.
21. Schwiegelshohn B, Presley JF, Gorecki M, Vogel T, Carpentier YA, et al. (1995) Effects of apoprotein E on intracellular metabolism of model triglyceride-rich particles are distinct from effects on cell particle uptake. J Biol Chem 270: 1761-1769.
22. Ho YY, Al-Haideri M, Mazzone T, Vogel T, Presley JF, et al. (2000) Endogenously expressed apolipoprotein E has different effects on cell lipid metabolism as compared to exogenous apolipoprotein E carried on triglyceride-rich particles. Biochemistry 39: 4746-4754.
23. Stinton LM, Shaffer EA, (2012) Epidemiology of gallbladder disease: cholelithiasis and cancer. Gut Liver 6: 172-187.
24. Shaffer EA, (2005) Epidemiology and risk factors for gallstone disease: has the paradigm changed in the 21st century? Curr Gastroenterol Rep 7: 132-140.
25. Buch S, Schafmayer C, Volzke H, Becker C, Franke A, et al. (2007) A genome-wide association scan identifies the hepatic cholesterol transporter ABCG8 as a susceptibility factor for human gallstone disease. Nat Genet 39: 995-999.
26. Kervinen K, Savolainen MJ, Salokannel J, Hynninen A, Heikkinen J, et al. (1994) Apolipoprotein E and B polymorphisms-longevity factors assessed in nonagenarians. Atherosclerosis 105: 89-95.
27. DiPietro NA, (2010) Methods in epidemiology: observational study designs. Pharmacotherapy 30: 973-984.
28. Jiang ZY, Parini P, Eggertsen G, Davis MA, Hu H, et al. (2008) Increased expression of LXR alpha, ABCG5, ABCG8, and SR-BI in the liver from normolipidemic, nonobese Chinese gallstone patients. J Lipid Res 49: 464-472.